News Focus
News Focus
Followers 2
Posts 736
Boards Moderated 0
Alias Born 05/16/2017

Re: Biotech Pharmer post# 12161

Wednesday, 11/08/2017 5:34:15 PM

Wednesday, November 08, 2017 5:34:15 PM

Post# of 20617
No, Damaj knows enough about marketing and he now has an expert to do it.
Damaj made a very smart move to acquire the BH platform for a great price. It's now the backbone of their marketing machinery and has proven that it enables them to sell millions worth of single supplements. A great achievement. Fine tuning of costs is the next step after the current wave of new products has been fully integrated into the BH platform.

The only truly condescending behavior is yours. You pose as the know it all chief critic of Damaj, yet when your statements are scrutinized, a large vacuum is revealed where one would expect a library of hard facts about INNV.
There is nothing that makes you capable of giving altruistic investment advise about INNV. In fact, you are actively misleading people by constantly spreading false or exaggerated information. I've proven it again just a few minutes ago.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today